BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15154641)

  • 21. Rapid and label-free detection of breast cancer biomarker CA15-3 in clinical human serum samples with optofluidic ring resonator sensors.
    Zhu H; Dale PS; Caldwell CW; Fan X
    Anal Chem; 2009 Dec; 81(24):9858-65. PubMed ID: 19911811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profiling tumor-associated autoantibodies for the detection of colon cancer.
    Ran Y; Hu H; Zhou Z; Yu L; Sun L; Pan J; Liu J; Yang Z
    Clin Cancer Res; 2008 May; 14(9):2696-700. PubMed ID: 18451234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head.
    Liao Q; Zhao YP; Yang YC; Li LJ; Long X; Han SM
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):641-5. PubMed ID: 18086633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic value of serum CA242, CA 19-9, CA 15-3 and CA 125 in patients with carcinoma of the gallbladder.
    Shukla VK; Gurubachan ; Sharma D; Dixit VK; Usha
    Trop Gastroenterol; 2006; 27(4):160-5. PubMed ID: 17542293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tumor markers in gynecological and breast cancer].
    Jobo T; Sato R; Kuramoto H
    Rinsho Byori; 2003 Dec; 51(12):1188-94. PubMed ID: 14743742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Application of multiple tumor markers's protein chip in the screen program of the elderly].
    Yan HY; Zhong RH; Li J; Luo XH; Chen R
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Sep; 32(9):924-6. PubMed ID: 22340884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ; Du J; Pang D
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of tumor markers biochip C12 system in the diagnosis of gastric cancer and the strategies for improvement: analysis of 100 cases.
    Chen C; Chen LQ; Chen LD; Yang GL; Li Y
    Hepatogastroenterology; 2008; 55(84):991-7. PubMed ID: 18705314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of a method for the simultaneous detection of multiple tumor markers using a multiplex suspension bead array.
    Wang Y; Fang F; Shi C; Zhang X; Liu L; Li J; Zhou X; Yao J; Kang X
    Clin Biochem; 2012 Nov; 45(16-17):1394-8. PubMed ID: 22820436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Developing a hospital-based high risk scoring model and screening strategy for pancreatic cancer].
    Deng RX; Lu XH; Wang L; Li H; Qian JM; Yang AM; Zhong SX; Guo XZ; Zhou L; Wu X; Yang XO; Jiang WJ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2038-42. PubMed ID: 16313796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Application of serum protein fingerprint model and support vector machine in diagnosis of thyroid cancer].
    Wang JX; Wang L; Fan YZ; Liu QL; Zhang J; Yu JK; Zheng S
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):979-82. PubMed ID: 16759540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemiluminescence imaging immunoassay of multiple tumor markers for cancer screening.
    Zong C; Wu J; Wang C; Ju H; Yan F
    Anal Chem; 2012 Mar; 84(5):2410-5. PubMed ID: 22320247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The value of tumor markers in digestive oncology].
    Ychou M; Rougier P; Bidart JM; Bellet D; Tigaud JM; Bohuon C
    Ann Chir; 1989; 43(7):517-23. PubMed ID: 2694905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of tumor markers and their clinical significance in epithelial ovarian cancer.
    Shan D; Cheng S; Ma Y; Peng H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Jul; 48(7):1039-1049. PubMed ID: 37724407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N(1),N(12)-Diacetylspermine as a sensitive and specific novel marker for early- and late-stage colorectal and breast cancers.
    Hiramatsu K; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H; Tanaka S; Tanaka C; Tamamori Y; Imajo M; Kawaguchi M; Toi M; Mori T; Kawakita M
    Clin Cancer Res; 2005 Apr; 11(8):2986-90. PubMed ID: 15837752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early diagnosis of lung cancer by detection of tumor liberated protein.
    Tarro G; Perna A; Esposito C
    J Cell Physiol; 2005 Apr; 203(1):1-5. PubMed ID: 15389637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens.
    Draghici S; Chatterjee M; Tainsky MA
    Expert Rev Mol Diagn; 2005 Sep; 5(5):735-43. PubMed ID: 16149876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor markers in staging and prognosis of colorectal carcinoma.
    Levy M; Visokai V; Lipska L; Topolcan O
    Neoplasma; 2008; 55(2):138-42. PubMed ID: 18237252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a new automated enzyme immunoassay for the determination of neuron-specific enolase.
    Sterk M; Oenings A; Eymann E; Roos W
    Anticancer Res; 1999; 19(4A):2759-62. PubMed ID: 10470236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour M2-pyruvate kinase: a gastrointestinal cancer marker.
    Kumar Y; Tapuria N; Kirmani N; Davidson BR
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):265-76. PubMed ID: 17301655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.